JP2008542376A - クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 - Google Patents
クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 Download PDFInfo
- Publication number
- JP2008542376A JP2008542376A JP2008514712A JP2008514712A JP2008542376A JP 2008542376 A JP2008542376 A JP 2008542376A JP 2008514712 A JP2008514712 A JP 2008514712A JP 2008514712 A JP2008514712 A JP 2008514712A JP 2008542376 A JP2008542376 A JP 2008542376A
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- oxo
- thia
- azabicyclo
- ene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003781 beta lactamase inhibitor Substances 0.000 title description 8
- 229940126813 beta-lactamase inhibitor Drugs 0.000 title description 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 77
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 60
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 58
- 150000001875 compounds Chemical class 0.000 claims abstract description 57
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims abstract description 20
- 239000002132 β-lactam antibiotic Substances 0.000 claims abstract description 20
- 229940124586 β-lactam antibiotics Drugs 0.000 claims abstract description 20
- 102000004190 Enzymes Human genes 0.000 claims abstract description 16
- 108090000790 Enzymes Proteins 0.000 claims abstract description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 15
- 239000001257 hydrogen Substances 0.000 claims abstract description 13
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 8
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 226
- -1 substituted Chemical class 0.000 claims description 139
- 229910052799 carbon Inorganic materials 0.000 claims description 70
- 125000003118 aryl group Chemical group 0.000 claims description 48
- 229910052757 nitrogen Inorganic materials 0.000 claims description 46
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 44
- 159000000000 sodium salts Chemical class 0.000 claims description 40
- 150000001721 carbon Chemical group 0.000 claims description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 35
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 claims description 34
- 125000000217 alkyl group Chemical group 0.000 claims description 34
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 30
- FYZUENZXIZCLAZ-UHFFFAOYSA-N 2-methylhept-2-enoic acid Chemical compound CCCCC=C(C)C(O)=O FYZUENZXIZCLAZ-UHFFFAOYSA-N 0.000 claims description 30
- 229920006395 saturated elastomer Polymers 0.000 claims description 26
- 125000005842 heteroatom Chemical group 0.000 claims description 21
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
- 125000003003 spiro group Chemical group 0.000 claims description 11
- 125000003107 substituted aryl group Chemical group 0.000 claims description 11
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 10
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000002950 monocyclic group Chemical group 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 125000005018 aryl alkenyl group Chemical group 0.000 claims description 4
- 125000005325 aryloxy aryl group Chemical group 0.000 claims description 4
- 125000002619 bicyclic group Chemical group 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 4
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 4
- GRYKCKSOHDCZJF-YLBKJFSISA-N (5r,6z)-7-oxo-6-(4h-thieno[2,3]thiopyrano[2,4-b]pyridin-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1SC2=NC=CC=C2C(S2)=C1C=C2/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O GRYKCKSOHDCZJF-YLBKJFSISA-N 0.000 claims description 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 3
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 3
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- RLYFCCSEWJKCQN-LEPFTWFBSA-N chembl1162147 Chemical compound C1OCCC2=C1OC1=CC(/C=C3/C(=O)N4[C@@H]3SC=C4C(=O)O)=NN12 RLYFCCSEWJKCQN-LEPFTWFBSA-N 0.000 claims description 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 3
- 125000005226 heteroaryloxycarbonyl group Chemical group 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- RITQDZWBRPLXHO-NUZRTGFDSA-N (5R,6Z)-7-oxo-6-[[7-(2-phenylmethoxyethoxy)-1,8,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraen-11-yl]methylidene]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1([C@@H]2SC=C1C(=O)O)C(=O)\C2=C\C(N=C1N=2)=CN1C=1CCCC=1C=2OCCOCC1=CC=CC=C1 RITQDZWBRPLXHO-NUZRTGFDSA-N 0.000 claims description 2
- AHICGCNKVSGCLQ-WSVPDTOYSA-N (5r,6z)-7-oxo-6-(spiro[1,3-dioxolane-2,7'-8,9-dihydro-6h-[1,2,4]triazolo[1,5-a]quinazoline]-2'-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1([C@@H]2SC=C1C(=O)O)C(=O)\C2=C\C(=NN1C=2CC3)N=C1N=CC=2CC13OCCO1 AHICGCNKVSGCLQ-WSVPDTOYSA-N 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 2
- OWKFKAWHZKUXBM-WSVPDTOYSA-N (5R,6Z)-6-[(7-methoxy-1,8,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraen-11-yl)methylidene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound COC1=NC2=NC(\C=C/3C(N4C(=CS[C@@H]4\3)C(O)=O)=O)=CN2C2=C1CCC2 OWKFKAWHZKUXBM-WSVPDTOYSA-N 0.000 claims 1
- LVDAGEHCAGXUMS-VYLZPFMQSA-N (5R,6Z)-7-oxo-6-([1,3]thiazolo[3,2-a]benzimidazol-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S1C2=NC3=CC=CC=C3N2C=C1/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O LVDAGEHCAGXUMS-VYLZPFMQSA-N 0.000 claims 1
- FNBVVWRNKCSCSF-JKLGPDONSA-N (5r,6e)-6-[(5-benzyl-6-oxobenzo[b][1,4]benzoxazepin-3-yl)methylidene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1([C@@H]2SC=C1C(=O)O)C(=O)\C2=C/C(C=C12)=CC=C1OC1=CC=CC=C1C(=O)N2CC1=CC=CC=C1 FNBVVWRNKCSCSF-JKLGPDONSA-N 0.000 claims 1
- ZMVPSTWCZFOKMA-VYLZPFMQSA-N (5r,6z)-6-(1,2-dihydro-[1,3]thiazolo[3,2-a]benzimidazol-7-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1([C@@H]2SC=C1C(=O)O)C(=O)\C2=C\C(C=C12)=CC=C1N=C1N2CCS1 ZMVPSTWCZFOKMA-VYLZPFMQSA-N 0.000 claims 1
- UIEWFJZVZVDQLA-IZIDJEDMSA-N (5r,6z)-6-(3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazol-7-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S1CCCN2C3=CC(/C=C4/C(=O)N5[C@@H]4SC=C5C(=O)O)=CC=C3N=C21 UIEWFJZVZVDQLA-IZIDJEDMSA-N 0.000 claims 1
- SBFSPMJWFBHKNG-UUKWBXHYSA-N (5r,6z)-6-(imidazo[1,2-a]quinolin-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1=C2C=CC3=CC=CC=C3N2C=C1/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O SBFSPMJWFBHKNG-UUKWBXHYSA-N 0.000 claims 1
- SWNURUJCQSUVHE-MGDKSHQASA-N (5r,6z)-6-(imidazo[1,2-a]quinoxalin-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1=C2C=NC3=CC=CC=C3N2C=C1/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O SWNURUJCQSUVHE-MGDKSHQASA-N 0.000 claims 1
- ZQZVENIYZGCSFN-VYLZPFMQSA-N (5r,6z)-6-(imidazo[2,1-b][1,3]benzothiazol-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1=C2SC3=CC=CC=C3N2C=C1/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O ZQZVENIYZGCSFN-VYLZPFMQSA-N 0.000 claims 1
- VOFYPSOWJHHFAS-IZIDJEDMSA-N (5r,6z)-6-[(5-methyl-6,7,8,9-tetrahydro-[1,2,4]triazolo[1,5-a]quinazolin-2-yl)methylidene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1CCCC2=C1N1N=C(\C=C/3C(N4C(=CS[C@@H]4\3)C(O)=O)=O)N=C1N=C2C VOFYPSOWJHHFAS-IZIDJEDMSA-N 0.000 claims 1
- GVIJNDBUPIEBNV-VYLZPFMQSA-N (5r,6z)-6-[(5-methyl-7,8-dihydro-6h-cyclopenta[e][1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound CC1=NC2=NC(\C=C/3C(N4C(=CS[C@@H]4\3)C(O)=O)=O)=NN2C2=C1CCC2 GVIJNDBUPIEBNV-VYLZPFMQSA-N 0.000 claims 1
- IAUJWOFPTCUPKI-WSVPDTOYSA-N (5r,6z)-6-{[7-(ethoxycarbonyl)-6,7,8,9-tetrahydropyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methylene}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1=NC2=NC(\C=C/3C(N4C(=CS[C@@H]4\3)C(O)=O)=O)=NN2C2=C1CN(C(=O)OCC)CC2 IAUJWOFPTCUPKI-WSVPDTOYSA-N 0.000 claims 1
- WBVGDYUBKRMKNU-HMZQOCAUSA-N (5r,6z)-7-oxo-6-(5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]benzoxazol-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1CCCC2=C1OC1=CC(/C=C3/C(=O)N4[C@@H]3SC=C4C(=O)O)=NN12 WBVGDYUBKRMKNU-HMZQOCAUSA-N 0.000 claims 1
- YJHLAPIOTYDKSI-VYLZPFMQSA-N (5r,6z)-7-oxo-6-([1,3]thiazolo[3,2-a]benzimidazol-7-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1([C@@H]2SC=C1C(=O)O)C(=O)\C2=C\C(C=C12)=CC=C1N=C1N2C=CS1 YJHLAPIOTYDKSI-VYLZPFMQSA-N 0.000 claims 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 claims 1
- 150000003973 alkyl amines Chemical class 0.000 claims 1
- XFARUGBBAMTOCU-IBSXUBTNSA-N chembl1205614 Chemical compound C1CCC(SC2=N3)=C1N2C=C3/C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O XFARUGBBAMTOCU-IBSXUBTNSA-N 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- GDDZRTPUGYRYNK-IZRWNGHKSA-M sodium;(5r,6z)-7-oxo-6-(5,6,7,8-tetrahydroimidazo[1,2][1,2,4]triazolo[2,4-a]pyridin-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Na+].C1CCCC2=NC3=NC(/C=C4/C(=O)N5[C@@H]4SC=C5C(=O)[O-])=CN3N21 GDDZRTPUGYRYNK-IZRWNGHKSA-M 0.000 claims 1
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 1
- 102000006635 beta-lactamase Human genes 0.000 abstract description 10
- 108090000204 Dipeptidase 1 Proteins 0.000 abstract description 4
- 206010034133 Pathogen resistance Diseases 0.000 abstract description 4
- 239000003112 inhibitor Substances 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 445
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 300
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 212
- 239000011541 reaction mixture Substances 0.000 description 186
- 235000019439 ethyl acetate Nutrition 0.000 description 150
- 239000000203 mixture Substances 0.000 description 130
- 239000000243 solution Substances 0.000 description 121
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 118
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 117
- 238000002360 preparation method Methods 0.000 description 113
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 111
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 108
- 239000007787 solid Substances 0.000 description 108
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 99
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 90
- 239000000047 product Substances 0.000 description 88
- 230000002829 reductive effect Effects 0.000 description 72
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 67
- 239000012044 organic layer Substances 0.000 description 66
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 63
- 239000000706 filtrate Substances 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 239000010410 layer Substances 0.000 description 58
- 238000006243 chemical reaction Methods 0.000 description 55
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 54
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 51
- 238000005160 1H NMR spectroscopy Methods 0.000 description 49
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 40
- 239000011888 foil Substances 0.000 description 40
- 239000012267 brine Substances 0.000 description 39
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 39
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 35
- 239000008363 phosphate buffer Substances 0.000 description 34
- 239000002244 precipitate Substances 0.000 description 33
- 125000001424 substituent group Chemical group 0.000 description 32
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 31
- 238000010898 silica gel chromatography Methods 0.000 description 28
- 238000004440 column chromatography Methods 0.000 description 26
- 239000013078 crystal Substances 0.000 description 26
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 238000001816 cooling Methods 0.000 description 22
- 239000011734 sodium Substances 0.000 description 22
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 21
- 235000019341 magnesium sulphate Nutrition 0.000 description 21
- 230000002441 reversible effect Effects 0.000 description 21
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 20
- 238000000746 purification Methods 0.000 description 20
- 229920005989 resin Polymers 0.000 description 20
- 239000011347 resin Substances 0.000 description 20
- 239000012300 argon atmosphere Substances 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 239000008367 deionised water Substances 0.000 description 18
- 229910021641 deionized water Inorganic materials 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 17
- 229910002027 silica gel Inorganic materials 0.000 description 17
- 239000007858 starting material Substances 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- BCQLGSCBQKKBIM-CMPLNLGQSA-N (4-nitrophenyl)methyl (5r,6s)-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)C1=CS[C@H]2N1C(=O)[C@@H]2Br BCQLGSCBQKKBIM-CMPLNLGQSA-N 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 239000012429 reaction media Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 239000000428 dust Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 239000000460 chlorine Substances 0.000 description 12
- 239000002274 desiccant Substances 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 150000001299 aldehydes Chemical class 0.000 description 10
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 10
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 125000000304 alkynyl group Chemical group 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- VICYTAYPKBLQFB-UHFFFAOYSA-N ethyl 3-bromo-2-oxopropanoate Chemical compound CCOC(=O)C(=O)CBr VICYTAYPKBLQFB-UHFFFAOYSA-N 0.000 description 8
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- BCQLGSCBQKKBIM-UHFFFAOYSA-N (4-nitrophenyl)methyl 6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)C1=CSC2N1C(=O)C2Br BCQLGSCBQKKBIM-UHFFFAOYSA-N 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- 239000012299 nitrogen atmosphere Substances 0.000 description 7
- 229960002292 piperacillin Drugs 0.000 description 7
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 7
- 108020004256 Beta-lactamase Proteins 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- JGZKUKYUQJUUNE-UHFFFAOYSA-L magnesium;ethoxyethane;dibromide Chemical compound [Mg+2].[Br-].[Br-].CCOCC JGZKUKYUQJUUNE-UHFFFAOYSA-L 0.000 description 6
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 238000004007 reversed phase HPLC Methods 0.000 description 6
- 238000002390 rotary evaporation Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 5
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- DUNKKIRUWZSMPT-UHFFFAOYSA-N 7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CSC2CC(=O)N12 DUNKKIRUWZSMPT-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 4
- 229960003022 amoxicillin Drugs 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- WQWSMVWRGAFPJX-UHFFFAOYSA-N (3-amino-1h-1,2,4-triazol-5-yl)methanol Chemical compound NC1=NNC(CO)=N1 WQWSMVWRGAFPJX-UHFFFAOYSA-N 0.000 description 3
- UUVDQMYRPUHXPB-UHFFFAOYSA-N 1,3-benzothiazole-2-carboxylic acid Chemical compound C1=CC=C2SC(C(=O)O)=NC2=C1 UUVDQMYRPUHXPB-UHFFFAOYSA-N 0.000 description 3
- PRRZDZJYSJLDBS-UHFFFAOYSA-N 3-bromo-2-oxopropanoic acid Chemical compound OC(=O)C(=O)CBr PRRZDZJYSJLDBS-UHFFFAOYSA-N 0.000 description 3
- JIDGUKIAUDLAQP-UHFFFAOYSA-N 4-chloro-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-amine Chemical compound ClC1=NC(N)=NC2=C1CCC2 JIDGUKIAUDLAQP-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- 239000012448 Lithium borohydride Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000007832 Na2SO4 Substances 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- IHCQWURUZRYCIU-UHFFFAOYSA-N [1,3]thiazolo[3,2-a]benzimidazole Chemical compound C1=CC=C2N3C=CSC3=NC2=C1 IHCQWURUZRYCIU-UHFFFAOYSA-N 0.000 description 3
- 150000001336 alkenes Chemical group 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 125000006574 non-aromatic ring group Chemical group 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 3
- UXNHGUHIZFIJOE-HWDGFJGFSA-N (4-nitrophenyl)methyl (5r)-6-[acetyloxy(5,6,7,8-tetrahydroimidazo[1,2][1,2,4]triazolo[2,4-a]pyridin-2-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(C=2N=C3N=C4CCCCN4N3C=2)OC(=O)C)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 UXNHGUHIZFIJOE-HWDGFJGFSA-N 0.000 description 2
- VQWYSTGIQKLGAL-WVZVXSGGSA-N (5r,6s)-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CS[C@@H]2[C@@H](Br)C(=O)N12 VQWYSTGIQKLGAL-WVZVXSGGSA-N 0.000 description 2
- DSTTYPFMKAGFDF-UHFFFAOYSA-N (6-chloroimidazo[2,1-b][1,3]benzothiazol-2-yl)methanol Chemical compound ClC1=CC=C2N3C=C(CO)N=C3SC2=C1 DSTTYPFMKAGFDF-UHFFFAOYSA-N 0.000 description 2
- ORNBQIBEFMMLKI-UHFFFAOYSA-N (6-methoxyimidazo[2,1-b][1,3]benzothiazol-2-yl)methanol Chemical compound COC1=CC=C2N3C=C(CO)N=C3SC2=C1 ORNBQIBEFMMLKI-UHFFFAOYSA-N 0.000 description 2
- OKBVVJOGVLARMR-QMTHXVAHSA-N (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1C(N)=NC(C(=NOCC(O)=O)C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QMTHXVAHSA-N 0.000 description 2
- DNSSZSIFBDAYBH-UHFFFAOYSA-N (8-methyl-6,7-dihydro-5h-cyclopenta[d][1,2,4] triazolo [1,5-a]pyrimidin-2-yl)-methanol Chemical compound CC1=C2CCCC2=NC2=NC(CO)=NN12 DNSSZSIFBDAYBH-UHFFFAOYSA-N 0.000 description 2
- ARLYYCBPYZEELO-UHFFFAOYSA-N (8-methylimidazo[2,1-b][1,3]benzothiazol-2-yl)methanol Chemical compound CC1=CC=CC2=C1N1C=C(CO)N=C1S2 ARLYYCBPYZEELO-UHFFFAOYSA-N 0.000 description 2
- 125000006828 (C2-C7) alkoxycarbonyl group Chemical group 0.000 description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 2
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 2
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 description 2
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 description 2
- MWZDIEIXRBWPLG-UHFFFAOYSA-N 1-methyl-1,2,4-triazole Chemical compound CN1C=NC=N1 MWZDIEIXRBWPLG-UHFFFAOYSA-N 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- OMAFFHIGWTVZOH-UHFFFAOYSA-N 1-methyltetrazole Chemical compound CN1C=NN=N1 OMAFFHIGWTVZOH-UHFFFAOYSA-N 0.000 description 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 2
- YVONCYKXWZJWHM-UHFFFAOYSA-N 2,3-dihydrothiopyrano[2,3-b]pyridin-4-one Chemical compound C1=CC=C2C(=O)CCSC2=N1 YVONCYKXWZJWHM-UHFFFAOYSA-N 0.000 description 2
- GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 2
- SURMYNZXHKLDFO-UHFFFAOYSA-N 2-bromopropanedial Chemical compound O=CC(Br)C=O SURMYNZXHKLDFO-UHFFFAOYSA-N 0.000 description 2
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 2
- DSOSRDUMMIZDMQ-UHFFFAOYSA-N 3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazol-7-ylmethanol Chemical compound S1CCCN2C3=CC(CO)=CC=C3N=C21 DSOSRDUMMIZDMQ-UHFFFAOYSA-N 0.000 description 2
- RWBYJFITRDZHED-UHFFFAOYSA-N 3-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=C(Br)SC2CC(=O)N12 RWBYJFITRDZHED-UHFFFAOYSA-N 0.000 description 2
- XIDRPBLMCNOUKH-UHFFFAOYSA-N 4,10-dihydropyrazolo[5,1-c][1,4]benzoxazepin-2-ylmethanol Chemical compound C1OC2=CC=CC=C2CN2N=C(CO)C=C21 XIDRPBLMCNOUKH-UHFFFAOYSA-N 0.000 description 2
- SHOGZVTYTBWSKC-UHFFFAOYSA-N 4,10-dihydropyrazolo[5,1-c][1,4]benzoxazepine-2-carbaldehyde Chemical compound C1OC2=CC=CC=C2CN2N=C(C=O)C=C21 SHOGZVTYTBWSKC-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 2
- SBOAQTQFUPQKNP-UHFFFAOYSA-N 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1CCCN2N=C(N)N=C21 SBOAQTQFUPQKNP-UHFFFAOYSA-N 0.000 description 2
- JTOFFVRDJDUXLQ-UHFFFAOYSA-N 5-methyl-6,7,8,9-tetrahydro-[1,2,4]triazolo[1,5-a]quinazoline-2-carbaldehyde Chemical compound C1CCCC2=C1N1N=C(C=O)N=C1N=C2C JTOFFVRDJDUXLQ-UHFFFAOYSA-N 0.000 description 2
- LNAXTVLGKQLSDV-UHFFFAOYSA-N 6-[acetyloxy-(6-methylimidazo[2,1-b][1,3]benzothiazol-2-yl)methyl]-6-bromo-3-[(4-nitrophenyl)methyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C=1N(C2=CC=C(C)C=C2S2)C2=NC=1C(OC(=O)C)C(C(N1C=2C(O)=O)=O)(Br)C1SC=2CC1=CC=C([N+]([O-])=O)C=C1 LNAXTVLGKQLSDV-UHFFFAOYSA-N 0.000 description 2
- ZGKMEGHDDKHEKQ-UHFFFAOYSA-N 6-chloroimidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound ClC1=CC=C2N3C=C(C=O)N=C3SC2=C1 ZGKMEGHDDKHEKQ-UHFFFAOYSA-N 0.000 description 2
- WGUJZKAPXBBTFN-UHFFFAOYSA-N 6-oxo-5h-benzo[b][1,4]benzoxazepine-3-carbaldehyde Chemical compound O=C1NC2=CC(C=O)=CC=C2OC2=CC=CC=C21 WGUJZKAPXBBTFN-UHFFFAOYSA-N 0.000 description 2
- QTJLXWKLTUCJAK-UHFFFAOYSA-N 8-methyl-6,7-dihydro-5h-cyclopenta[d][1,2,4]triazolo[-1,5-a]pyrimidine-2-carbaldehyde Chemical compound CC1=C2CCCC2=NC2=NC(C=O)=NN12 QTJLXWKLTUCJAK-UHFFFAOYSA-N 0.000 description 2
- JONCPBKONGUNNR-UHFFFAOYSA-N 8-methylimidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound CC1=CC=CC2=C1N1C=C(C=O)N=C1S2 JONCPBKONGUNNR-UHFFFAOYSA-N 0.000 description 2
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 2
- LYDGGDKACJPTNY-UHFFFAOYSA-N C1=NC2=NC=CN2C2=C1CCC2 Chemical group C1=NC2=NC=CN2C2=C1CCC2 LYDGGDKACJPTNY-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 0 CCCC(CC)*(****1)*1I Chemical compound CCCC(CC)*(****1)*1I 0.000 description 2
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 description 2
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 2
- JWCSIUVGFCSJCK-CAVRMKNVSA-N Disodium Moxalactam Chemical compound N([C@]1(OC)C(N2C(=C(CSC=3N(N=NN=3)C)CO[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C1=CC=C(O)C=C1 JWCSIUVGFCSJCK-CAVRMKNVSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- NABVVTDWRQBVTM-UHFFFAOYSA-N [1,3]thiazolo[3,2-a]benzimidazole-7-carbaldehyde Chemical compound C12=CC(C=O)=CC=C2N=C2N1C=CS2 NABVVTDWRQBVTM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000002393 azetidinyl group Chemical group 0.000 description 2
- 125000004069 aziridinyl group Chemical group 0.000 description 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
- 229960003644 aztreonam Drugs 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 2
- 229960003324 clavulanic acid Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- NNDPNVWFHNWWJD-UHFFFAOYSA-N diethyl 1-[(2-fluorophenyl)methyl]pyrazole-3,5-dicarboxylate Chemical compound N1=C(C(=O)OCC)C=C(C(=O)OCC)N1CC1=CC=CC=C1F NNDPNVWFHNWWJD-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000005047 dihydroimidazolyl group Chemical group N1(CNC=C1)* 0.000 description 2
- 125000005048 dihydroisoxazolyl group Chemical group O1N(CC=C1)* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RSYXVNXPUMGKNX-UHFFFAOYSA-N ethyl 4-(hydroxymethyl)-2,3,5,7,11-pentazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7-tetraene-11-carboxylate Chemical compound C1=NC2=NC(CO)=NN2C2=C1CN(C(=O)OCC)CC2 RSYXVNXPUMGKNX-UHFFFAOYSA-N 0.000 description 2
- YHHXHXVYJGQWEC-UHFFFAOYSA-N ethyl 4-formyl-2,3,5,7,11-pentazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7-tetraene-11-carboxylate Chemical compound C1=NC2=NC(C=O)=NN2C2=C1CN(C(=O)OCC)CC2 YHHXHXVYJGQWEC-UHFFFAOYSA-N 0.000 description 2
- VEEWNVLWBJTTEM-UHFFFAOYSA-N ethyl 8-methylimidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound C1=CC(C)=C2N3C=C(C(=O)OCC)N=C3SC2=C1 VEEWNVLWBJTTEM-UHFFFAOYSA-N 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- CKPKCVPIDQOXIW-UHFFFAOYSA-N imidazo[2,1-b][1,3]benzothiazol-2-ylmethanol Chemical compound C1=CC=C2N3C=C(CO)N=C3SC2=C1 CKPKCVPIDQOXIW-UHFFFAOYSA-N 0.000 description 2
- RBQGKSWYSQGVDV-UHFFFAOYSA-N imidazo[2,1-b][1,3]benzothiazole Chemical group C1=CC=C2N3C=CN=C3SC2=C1 RBQGKSWYSQGVDV-UHFFFAOYSA-N 0.000 description 2
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 2
- 229960002182 imipenem Drugs 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- 229960000433 latamoxef Drugs 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 2
- 229960001019 oxacillin Drugs 0.000 description 2
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- WDCSHWOJKPLGCU-UHFFFAOYSA-N pyrazolo[5,1-b][1,3]thiazole-2-carbaldehyde Chemical compound S1C=2N(C=C1C=O)N=CC=2 WDCSHWOJKPLGCU-UHFFFAOYSA-N 0.000 description 2
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- YTTDMRAHJMTSGT-UHPXVVQNSA-M sodium;(6z)-6-(5h-imidazo[2,1-a]isoindol-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Na+].C1=CC=C2C3=NC(/C=C4/C(=O)N5C4SC=C5C(=O)[O-])=CN3CC2=C1 YTTDMRAHJMTSGT-UHPXVVQNSA-M 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 2
- 229960005256 sulbactam Drugs 0.000 description 2
- 229960003865 tazobactam Drugs 0.000 description 2
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 2
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 2
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 2
- 229960004659 ticarcillin Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JETQIUPBHQNHNZ-NJBDSQKTSA-N (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[[(2r)-2-phenyl-2-sulfoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound C1([C@H](C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)S(O)(=O)=O)=CC=CC=C1 JETQIUPBHQNHNZ-NJBDSQKTSA-N 0.000 description 1
- WKEIBPXHIIHMFD-SDPJGKNGSA-N (4-nitrophenyl)methyl (5R)-6-[acetyloxy(7,10-dioxa-2,3-diazatricyclo[6.4.0.02,6]dodeca-1(8),3,5-trien-4-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound C(C)(=O)OC(C1([C@H]2SC=C(N2C1=O)C(=O)OCC1=CC=C(C=C1)[N+](=O)[O-])Br)C1=NN2C(OC3=C2CCOC3)=C1 WKEIBPXHIIHMFD-SDPJGKNGSA-N 0.000 description 1
- KAVALDJLVJKCNZ-JKJRPBHFSA-N (4-nitrophenyl)methyl (5r)-6-[acetyloxy(5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazol-2-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(C=2N=C3SC=4CCCCC=4N3C=2)OC(=O)C)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 KAVALDJLVJKCNZ-JKJRPBHFSA-N 0.000 description 1
- GBPZTKZSUBBYTF-DKEBNAFJSA-N (4-nitrophenyl)methyl (5r)-6-[acetyloxy(5h-imidazo[2,1-a]isoindol-2-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(C=2N=C3C4=CC=CC=C4CN3C=2)OC(=O)C)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 GBPZTKZSUBBYTF-DKEBNAFJSA-N 0.000 description 1
- BUBFPQHGVCSQIP-VJZLMVMKSA-N (4-nitrophenyl)methyl (5r)-6-[acetyloxy(imidazo[1,2-a]quinolin-2-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(C=2N=C3N(C4=CC=CC=C4C=C3)C=2)OC(=O)C)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 BUBFPQHGVCSQIP-VJZLMVMKSA-N 0.000 description 1
- KUCLPHIFMQCSGG-CNKRIOBRSA-N (4-nitrophenyl)methyl (5r)-6-[acetyloxy-(5-methyl-6,7,8,9-tetrahydro-[1,2,4]triazolo[1,5-a]quinazolin-2-yl)methyl]-6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(C2=NN3C=4CCCCC=4C(C)=NC3=N2)OC(=O)C)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 KUCLPHIFMQCSGG-CNKRIOBRSA-N 0.000 description 1
- XHIQSYLMJAVDLM-UHFFFAOYSA-N (4-nitrophenyl)methyl 2-methylhept-2-enoate Chemical compound CCCCC=C(C)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 XHIQSYLMJAVDLM-UHFFFAOYSA-N 0.000 description 1
- HNRFPWBGIROIJB-UHFFFAOYSA-N (4-nitrophenyl)methyl 3-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)C1=C(Br)SC2N1C(=O)C2 HNRFPWBGIROIJB-UHFFFAOYSA-N 0.000 description 1
- ZEFXZUXZVNMLNB-UHFFFAOYSA-N (4-nitrophenyl)methyl 6-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [N+](=O)([O-])C1=CC=C(COC(=O)C=2N3CC(C3SC2)=O)C=C1 ZEFXZUXZVNMLNB-UHFFFAOYSA-N 0.000 description 1
- XWYYINXUXYJYHY-UHFFFAOYSA-N (5-methyl-6,7,8,9-tetrahydro-[1,2,4]triazolo[1,5-a]quinazolin-2-yl)methanol Chemical compound C1CCCC2=C1N1N=C(CO)N=C1N=C2C XWYYINXUXYJYHY-UHFFFAOYSA-N 0.000 description 1
- TVXJEJRKLDFLJD-SDMSXHDGSA-N (5R)-3-bromo-4-thia-1-azabicyclo[3.2.0]heptan-7-one Chemical compound S1C(Br)CN2C(=O)C[C@H]21 TVXJEJRKLDFLJD-SDMSXHDGSA-N 0.000 description 1
- JDHDBYKBRYTFSV-JKJRPBHFSA-N (5R)-6-[acetyloxy([1,3]thiazolo[3,2-a]benzimidazol-2-yl)methyl]-6-bromo-3-[(4-nitrophenyl)methyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S([C@@H]1C(C(N1C=1C(O)=O)=O)(Br)C(C=2SC=3N(C4=CC=CC=C4N=3)C=2)OC(=O)C)C=1CC1=CC=C([N+]([O-])=O)C=C1 JDHDBYKBRYTFSV-JKJRPBHFSA-N 0.000 description 1
- JOTOKRKLBJCJTF-JIOITTSWSA-N (5r,6e)-6-(4,10-dihydropyrazolo[5,1-c][1,4]benzoxazepin-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1=C2COC3=CC=CC=C3CN2N=C1\C=C1/C(=O)N2[C@@H]1SC=C2C(=O)O JOTOKRKLBJCJTF-JIOITTSWSA-N 0.000 description 1
- KJZZJLBFVGGUKL-UHFFFAOYSA-N (6-fluoroimidazo[2,1-b][1,3]benzothiazol-2-yl)methanol Chemical compound FC1=CC=C2N3C=C(CO)N=C3SC2=C1 KJZZJLBFVGGUKL-UHFFFAOYSA-N 0.000 description 1
- SWNURUJCQSUVHE-YHYXMXQVSA-N (6Z)-6-(imidazo[1,2-a]quinoxalin-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C1=C(N=C2N1C1=CC=CC=C1N=C2)\C=C\1/C2SC=C(N2C/1=O)C(=O)O SWNURUJCQSUVHE-YHYXMXQVSA-N 0.000 description 1
- UCDIXJKWUCLMJK-XQRVVYSFSA-N (z)-2-bromo-3-propan-2-yloxyprop-2-enal Chemical compound CC(C)O\C=C(/Br)C=O UCDIXJKWUCLMJK-XQRVVYSFSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- VSHYSDNDLJBMAK-UHFFFAOYSA-N 1,2-dihydro-[1,3]thiazolo[3,2-a]benzimidazol-6-ylmethanol Chemical compound OCC1=CC=C2N(CCS3)C3=NC2=C1 VSHYSDNDLJBMAK-UHFFFAOYSA-N 0.000 description 1
- BGEHUNJNNLFWCN-UHFFFAOYSA-N 1,2-dihydro-[1,3]thiazolo[3,2-a]benzimidazole Chemical compound C1=CC=C2N3CCSC3=NC2=C1 BGEHUNJNNLFWCN-UHFFFAOYSA-N 0.000 description 1
- RXBAVTHQOJJXEZ-UHFFFAOYSA-N 1,2-dihydro-[1,3]thiazolo[3,2-a]benzimidazole-6-carbaldehyde Chemical compound O=CC1=CC=C2N(CCS3)C3=NC2=C1 RXBAVTHQOJJXEZ-UHFFFAOYSA-N 0.000 description 1
- RHKPJTFLRQNNGJ-UHFFFAOYSA-N 1,3-benzothiazole-2-carbaldehyde Chemical compound C1=CC=C2SC(C=O)=NC2=C1 RHKPJTFLRQNNGJ-UHFFFAOYSA-N 0.000 description 1
- MFAYHDNWECITJF-UHFFFAOYSA-N 1,3-benzoxazol-2-ylmethanol Chemical compound C1=CC=C2OC(CO)=NC2=C1 MFAYHDNWECITJF-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- VKPJOERCBNIOLN-UHFFFAOYSA-N 1,3-benzoxazole-2-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)=NC2=C1 VKPJOERCBNIOLN-UHFFFAOYSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- IJVLVRYLIMQVDD-UHFFFAOYSA-N 1,3-thiazole-2-carboxylic acid Chemical compound OC(=O)C1=NC=CS1 IJVLVRYLIMQVDD-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- FGYADSCZTQOAFK-UHFFFAOYSA-N 1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C=NC2=C1 FGYADSCZTQOAFK-UHFFFAOYSA-N 0.000 description 1
- AOLHUYZOMZLANT-UHFFFAOYSA-N 1-methylpyrazole 1H-pyrazole Chemical compound CN1N=CC=C1.N1N=CC=C1 AOLHUYZOMZLANT-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WYUJTZFSNZFXMI-UHFFFAOYSA-N 10-oxa-7-thia-2,5-diazatricyclo[6.4.0.02,6]dodeca-1(8),3,5-triene Chemical compound C1OCCC2=C1SC1=NC=CN21 WYUJTZFSNZFXMI-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- RHXSYTACTOMVLJ-UHFFFAOYSA-N 1H-benzimidazole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=NC2=C1 RHXSYTACTOMVLJ-UHFFFAOYSA-N 0.000 description 1
- GLCSVHYOQZPNQQ-UHFFFAOYSA-N 1h-cyclopenta[d]pyrimidin-2-amine Chemical compound N1C(N)=NC=C2C=CC=C21 GLCSVHYOQZPNQQ-UHFFFAOYSA-N 0.000 description 1
- CCRRYHDVZLKVNQ-UHFFFAOYSA-N 1h-indene-2-carbaldehyde Chemical compound C1=CC=C2CC(C=O)=CC2=C1 CCRRYHDVZLKVNQ-UHFFFAOYSA-N 0.000 description 1
- BECQKEAJAOJORW-UHFFFAOYSA-N 2-(2-carboxyethylsulfanyl)pyridine-3-carboxylic acid Chemical compound OC(=O)CCSC1=NC=CC=C1C(O)=O BECQKEAJAOJORW-UHFFFAOYSA-N 0.000 description 1
- UQRGFCOZZZCUDG-UHFFFAOYSA-N 2-(dimethylaminomethylidene)cyclohexan-1-one Chemical compound CN(C)C=C1CCCCC1=O UQRGFCOZZZCUDG-UHFFFAOYSA-N 0.000 description 1
- OSWDNIFICGLKEE-UHFFFAOYSA-N 2-acetylcyclopentan-1-one Chemical compound CC(=O)C1CCCC1=O OSWDNIFICGLKEE-UHFFFAOYSA-N 0.000 description 1
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
- CCHNWURRBFGQCD-UHFFFAOYSA-N 2-chlorocyclohexan-1-one Chemical compound ClC1CCCCC1=O CCHNWURRBFGQCD-UHFFFAOYSA-N 0.000 description 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WJAZPYLMQRYLAG-UHFFFAOYSA-N 2-methylhept-2-enoic acid 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]benzoxazole-2-carbaldehyde Chemical compound N1=C(C=C2OC3=C(N21)CCCC3)C=O.CC(=CCCCC)C(=O)O WJAZPYLMQRYLAG-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- PKEIUWCFINHFOC-UHFFFAOYSA-N 3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazole Chemical compound C1=CC=C2N(CCCS3)C3=NC2=C1 PKEIUWCFINHFOC-UHFFFAOYSA-N 0.000 description 1
- GGBLHWZOCKFJGV-UHFFFAOYSA-N 3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazole-7-carbaldehyde Chemical compound S1CCCN2C3=CC(C=O)=CC=C3N=C21 GGBLHWZOCKFJGV-UHFFFAOYSA-N 0.000 description 1
- FIZUQXLGABRGSR-UHFFFAOYSA-N 3,4-dihydropyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CCC1 FIZUQXLGABRGSR-UHFFFAOYSA-N 0.000 description 1
- VUWJPXBPTDYWJC-UHFFFAOYSA-N 3-(hydroxymethyl)-5h-benzo[b][1,4]benzoxazepin-6-one Chemical compound O=C1NC2=CC(CO)=CC=C2OC2=CC=CC=C21 VUWJPXBPTDYWJC-UHFFFAOYSA-N 0.000 description 1
- ZGULSQDBOSMIBZ-UHFFFAOYSA-N 3-bromooxan-4-one Chemical compound BrC1COCCC1=O ZGULSQDBOSMIBZ-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MTKKGHVQPVOXIL-UHFFFAOYSA-N 3h-isoindol-1-amine Chemical compound C1=CC=C2C(N)=NCC2=C1 MTKKGHVQPVOXIL-UHFFFAOYSA-N 0.000 description 1
- OUOHECWYYXAKEP-UHFFFAOYSA-N 4,10-dihydropyrazolo[5,1-c][1,4]benzoxazepine Chemical compound C1OC2=CC=CC=C2CN2N=CC=C12 OUOHECWYYXAKEP-UHFFFAOYSA-N 0.000 description 1
- GQIRZNBXMFVHOP-UHFFFAOYSA-N 4-(2-phenylmethoxyethoxy)-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-amine Chemical compound N=1C(N)=NC=2CCCC=2C=1OCCOCC1=CC=CC=C1 GQIRZNBXMFVHOP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
- KJTRXVXWSSPHRV-UHFFFAOYSA-N 4-benzoyl-5-methyl-2-phenyl-1h-pyrazol-3-one Chemical compound O=C1C(C(=O)C=2C=CC=CC=2)=C(C)NN1C1=CC=CC=C1 KJTRXVXWSSPHRV-UHFFFAOYSA-N 0.000 description 1
- YLGOHGPTMKKDMN-UHFFFAOYSA-N 4-chloro-2h-thiopyrano[2,3-b]pyridine-3-carbaldehyde Chemical compound C1=CC=C2C(Cl)=C(C=O)CSC2=N1 YLGOHGPTMKKDMN-UHFFFAOYSA-N 0.000 description 1
- MANPIKJAQIEAFO-UHFFFAOYSA-N 4-ethoxy-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-amine Chemical compound CCOC1=NC(N)=NC2=C1CCC2 MANPIKJAQIEAFO-UHFFFAOYSA-N 0.000 description 1
- CGAXGKAKKOLESL-UHFFFAOYSA-N 4-methoxy-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1CCC2 CGAXGKAKKOLESL-UHFFFAOYSA-N 0.000 description 1
- GRIATXVEXOFBGO-UHFFFAOYSA-N 4-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=CC2=C1N=C(N)S2 GRIATXVEXOFBGO-UHFFFAOYSA-N 0.000 description 1
- NMKTWLKSAFFGRL-UHFFFAOYSA-N 4-methylimidazo[1,2-a]benzimidazole-2-carbaldehyde Chemical compound CN1C2=CC=CC=C2N2C1=NC(C=O)=C2 NMKTWLKSAFFGRL-UHFFFAOYSA-N 0.000 description 1
- QJNLUNBGDFUULX-UHFFFAOYSA-N 4-n,4-n'-dimethyl-3h-pyridine-4,4-diamine Chemical compound CNC1(NC)CC=NC=C1 QJNLUNBGDFUULX-UHFFFAOYSA-N 0.000 description 1
- IWYXYMFQSVAJLW-UHFFFAOYSA-N 4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CSC2CCN12 IWYXYMFQSVAJLW-UHFFFAOYSA-N 0.000 description 1
- KNAROYMAYLAMFD-UHFFFAOYSA-N 4h-thieno[2,3]thiopyrano[2,4-b]pyridine Chemical group C1SC2=NC=CC=C2C2=C1C=CS2 KNAROYMAYLAMFD-UHFFFAOYSA-N 0.000 description 1
- BVVUGOXDSBCJRS-UHFFFAOYSA-N 5,6,7,8-tetrahydroimidazo[1,2][1,2,4]triazolo[2,4-a]pyridine-2-carbaldehyde Chemical compound C1CCCC2=NC3=NC(C=O)=CN3N21 BVVUGOXDSBCJRS-UHFFFAOYSA-N 0.000 description 1
- RQLKSKWLZQBUAV-UHFFFAOYSA-N 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]benzoxazole Chemical compound C1CCCC2=C1OC1=CC=NN21 RQLKSKWLZQBUAV-UHFFFAOYSA-N 0.000 description 1
- AJWFVIFZLWXPHP-UHFFFAOYSA-N 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]benzoxazole-2-carbaldehyde Chemical compound C1CCCC2=C1OC1=CC(C=O)=NN12 AJWFVIFZLWXPHP-UHFFFAOYSA-N 0.000 description 1
- ATZGPAXREWFWLU-UHFFFAOYSA-N 5-benzyl-6-oxobenzo[b][1,4]benzoxazepine-3-carbaldehyde Chemical compound C12=CC(C=O)=CC=C2OC2=CC=CC=C2C(=O)N1CC1=CC=CC=C1 ATZGPAXREWFWLU-UHFFFAOYSA-N 0.000 description 1
- PIYCGXANQSEAMD-UHFFFAOYSA-N 5-benzyloxyethoxy-7,8-dihydro-6h-3,4,8b-triaza-as-indacene-2-carboxylic acid ethyl ester Chemical compound N=1C2=NC(C(=O)OCC)=CN2C=2CCCC=2C=1OCCOCC1=CC=CC=C1 PIYCGXANQSEAMD-UHFFFAOYSA-N 0.000 description 1
- MBCXNURGCPAXSA-UHFFFAOYSA-N 5-ethoxy-7,8-dihydro-6h-3,4,8b-triaza-as-indacene-2-carbaldehyde Chemical compound CCOC1=NC2=NC(C=O)=CN2C2=C1CCC2 MBCXNURGCPAXSA-UHFFFAOYSA-N 0.000 description 1
- YNURUGWRNFWTJB-UHFFFAOYSA-N 5h-imidazo[2,1-a]isoindole Chemical compound C1=CC=C2C3=NC=CN3CC2=C1 YNURUGWRNFWTJB-UHFFFAOYSA-N 0.000 description 1
- COVBKHNWKAMFPT-UHFFFAOYSA-N 5h-imidazo[2,1-a]isoindole-2-carbaldehyde Chemical compound C1=CC=C2C3=NC(C=O)=CN3CC2=C1 COVBKHNWKAMFPT-UHFFFAOYSA-N 0.000 description 1
- ONYVQGKTBMWHDR-UHFFFAOYSA-N 6-[acetyloxy-(6-chloroimidazo[2,1-b][1,3]benzothiazol-2-yl)methyl]-6-bromo-3-[(4-nitrophenyl)methyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C=1N(C2=CC=C(Cl)C=C2S2)C2=NC=1C(OC(=O)C)C(C(N1C=2C(O)=O)=O)(Br)C1SC=2CC1=CC=C([N+]([O-])=O)C=C1 ONYVQGKTBMWHDR-UHFFFAOYSA-N 0.000 description 1
- JSHMBYLTRKZBBX-UHFFFAOYSA-N 6-[acetyloxy-(6-fluoroimidazo[2,1-b][1,3]benzothiazol-2-yl)methyl]-6-bromo-3-[(4-nitrophenyl)methyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C=1N(C2=CC=C(F)C=C2S2)C2=NC=1C(OC(=O)C)C(C(N1C=2C(O)=O)=O)(Br)C1SC=2CC1=CC=C([N+]([O-])=O)C=C1 JSHMBYLTRKZBBX-UHFFFAOYSA-N 0.000 description 1
- XSLISCIYAINSSD-UHFFFAOYSA-N 6-[acetyloxy-(8-methylimidazo[2,1-b][1,3]benzothiazol-2-yl)methyl]-6-bromo-3-[(4-nitrophenyl)methyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound C=1N(C2=C(C)C=CC=C2S2)C2=NC=1C(OC(=O)C)C(C(N1C=2C(O)=O)=O)(Br)C1SC=2CC1=CC=C([N+]([O-])=O)C=C1 XSLISCIYAINSSD-UHFFFAOYSA-N 0.000 description 1
- VQWYSTGIQKLGAL-UHFFFAOYSA-N 6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CSC2C(Br)C(=O)N12 VQWYSTGIQKLGAL-UHFFFAOYSA-N 0.000 description 1
- VMNXKIDUTPOHPO-UHFFFAOYSA-N 6-chloro-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C=C2SC(N)=NC2=C1 VMNXKIDUTPOHPO-UHFFFAOYSA-N 0.000 description 1
- GDGRILGGLAWGLS-UHFFFAOYSA-N 6-chloroimidazo[2,1-b][1,3]benzothiazole-2-carboxylic acid Chemical compound ClC1=CC=C2N3C=C(C(=O)O)N=C3SC2=C1 GDGRILGGLAWGLS-UHFFFAOYSA-N 0.000 description 1
- CJLUXPZQUXVJNF-UHFFFAOYSA-N 6-fluoro-1,3-benzothiazol-2-amine Chemical compound C1=C(F)C=C2SC(N)=NC2=C1 CJLUXPZQUXVJNF-UHFFFAOYSA-N 0.000 description 1
- KOFVJXCEFCOQAB-UHFFFAOYSA-N 6-fluoroimidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound FC1=CC=C2N3C=C(C=O)N=C3SC2=C1 KOFVJXCEFCOQAB-UHFFFAOYSA-N 0.000 description 1
- KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 description 1
- RCCRMTHKTBGESV-UHFFFAOYSA-N 6-methoxyimidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound COC1=CC=C2N3C=C(C=O)N=C3SC2=C1 RCCRMTHKTBGESV-UHFFFAOYSA-N 0.000 description 1
- KAOSMCALSKMYGV-UHFFFAOYSA-N 6-methoxyimidazo[2,1-b][1,3]benzothiazole-2-carboxylic acid Chemical compound COC1=CC=C2N3C=C(C(O)=O)N=C3SC2=C1 KAOSMCALSKMYGV-UHFFFAOYSA-N 0.000 description 1
- DZWTXWPRWRLHIL-UHFFFAOYSA-N 6-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=C2N=C(N)SC2=C1 DZWTXWPRWRLHIL-UHFFFAOYSA-N 0.000 description 1
- DYJJODUTVRNTPY-UHFFFAOYSA-N 6-methylimidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound CC1=CC=C2N3C=C(C=O)N=C3SC2=C1 DYJJODUTVRNTPY-UHFFFAOYSA-N 0.000 description 1
- ZIHSUWSBGLGENZ-UHFFFAOYSA-N 7,8-dihydro-5h-pyrano[4,3-d]pyrazolo[5,1-b][1,3]oxazol-2-carbaldehyde Chemical compound C1OCCC2=C1OC1=CC(C=O)=NN12 ZIHSUWSBGLGENZ-UHFFFAOYSA-N 0.000 description 1
- ZGCLRAKHOBQVSU-UHFFFAOYSA-N 7,8-dihydro-5h-pyrano[4,3-d]pyrazolo[5,1-b][1,3]oxazol-2-ylmethanol Chemical compound C1OCCC2=C1OC1=CC(CO)=NN12 ZGCLRAKHOBQVSU-UHFFFAOYSA-N 0.000 description 1
- OUQFEKKGHDGJAK-UHFFFAOYSA-N 7,8-dihydro-6h-cyclopenta[2,3]pyrazolo[2,4-b][1,3]thiazole Chemical compound C1=CSC2=C(CCC3)C3=NN21 OUQFEKKGHDGJAK-UHFFFAOYSA-N 0.000 description 1
- QOPVVFKNSPILEH-UHFFFAOYSA-N 7-oxo-6-(quinolin-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound N1=C(C=CC2=CC=CC=C12)C=C1C2SC=C(N2C1=O)C(=O)O QOPVVFKNSPILEH-UHFFFAOYSA-N 0.000 description 1
- IYRCUOUHMLBFGU-UHFFFAOYSA-N 7-thia-1,9-diazatricyclo[6.3.0.02,6]undeca-2(6),8,10-trien-10-yl 6-bromo-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound N=1C(=CN2C=1SC1=C2CCC1)OC(=O)C=1N2C(C(C2SC=1)Br)=O IYRCUOUHMLBFGU-UHFFFAOYSA-N 0.000 description 1
- CYDABVPVQMWWBC-UHFFFAOYSA-N 9h-fluorene-3-carbaldehyde Chemical compound C1=CC=C2C3=CC(C=O)=CC=C3CC2=C1 CYDABVPVQMWWBC-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- MKIYNTLLFPONQE-UHFFFAOYSA-N BrCC(C(=O)OCC)=O.C(C)OC(=O)C=1N=C2SC3=C(N2C1)C=CC=C3 Chemical compound BrCC(C(=O)OCC)=O.C(C)OC(=O)C=1N=C2SC3=C(N2C1)C=CC=C3 MKIYNTLLFPONQE-UHFFFAOYSA-N 0.000 description 1
- IAVGMEMFPVNZNY-UDTCPGNVSA-N C(C)(=O)OC(C1([C@H]2SC=C(N2C1=O)C(=O)OCC1=CC=C(C=C1)[N+](=O)[O-])Br)C1=NN2C(OC3=C2CCOC3)=C1.[Na] Chemical compound C(C)(=O)OC(C1([C@H]2SC=C(N2C1=O)C(=O)OCC1=CC=C(C=C1)[N+](=O)[O-])Br)C1=NN2C(OC3=C2CCOC3)=C1.[Na] IAVGMEMFPVNZNY-UDTCPGNVSA-N 0.000 description 1
- XRUOLCOGGUVBOW-GHVFDXJASA-N C(C)(=O)OC(C1([C@H]2SC=C(N2C1=O)C(=O)OCC1=CC=C(C=C1)[N+](=O)[O-])Br)C=1C=CC2=C(N3C(=N2)SC=C3)C1.CC(=CCCCC)C(=O)O Chemical compound C(C)(=O)OC(C1([C@H]2SC=C(N2C1=O)C(=O)OCC1=CC=C(C=C1)[N+](=O)[O-])Br)C=1C=CC2=C(N3C(=N2)SC=C3)C1.CC(=CCCCC)C(=O)O XRUOLCOGGUVBOW-GHVFDXJASA-N 0.000 description 1
- LQXGIIYXAFJKNI-UHFFFAOYSA-N C(C)OC(=O)C1=CN2C=3CCCC3C(=NC2=N1)OC.COC1=NC2=NC(=CN2C=2CCCC12)C=O Chemical compound C(C)OC(=O)C1=CN2C=3CCCC3C(=NC2=N1)OC.COC1=NC2=NC(=CN2C=2CCCC12)C=O LQXGIIYXAFJKNI-UHFFFAOYSA-N 0.000 description 1
- AMWBVZKDGWXFJV-UHFFFAOYSA-N C(C)OC(=O)C1=CN2C=3CCCC3C(=NC2=N1)OCCOCC1=CC=CC=C1.C(C1=CC=CC=C1)OCCOC1=NC2=NC(=CN2C=2CCCC12)C=O Chemical compound C(C)OC(=O)C1=CN2C=3CCCC3C(=NC2=N1)OCCOCC1=CC=CC=C1.C(C1=CC=CC=C1)OCCOC1=NC2=NC(=CN2C=2CCCC12)C=O AMWBVZKDGWXFJV-UHFFFAOYSA-N 0.000 description 1
- HMQVLFLIXLEMRJ-UHFFFAOYSA-N C(C)OC1=NC(=NC2=C1CCC2)N.C(C)OC(=O)C2=CN1C=3CCCC3C(=NC1=N2)OCC Chemical compound C(C)OC1=NC(=NC2=C1CCC2)N.C(C)OC(=O)C2=CN1C=3CCCC3C(=NC1=N2)OCC HMQVLFLIXLEMRJ-UHFFFAOYSA-N 0.000 description 1
- ZVSXCDSAHJZAIN-UHFFFAOYSA-N C(C)OC1=NC=NC2=C1CCC2.C(C)OC(=O)C2=CN1C=3CCCC3C(=NC1=N2)OC Chemical compound C(C)OC1=NC=NC2=C1CCC2.C(C)OC(=O)C2=CN1C=3CCCC3C(=NC1=N2)OC ZVSXCDSAHJZAIN-UHFFFAOYSA-N 0.000 description 1
- WJIYCZBAVWMTTL-UHFFFAOYSA-N C1=C(N=C2N1C1=CC=CC=C1C=C2)C=O.C2=C(N=C1N2C2=CC=CC=C2C=C1)C=O Chemical compound C1=C(N=C2N1C1=CC=CC=C1C=C2)C=O.C2=C(N=C1N2C2=CC=CC=C2C=C1)C=O WJIYCZBAVWMTTL-UHFFFAOYSA-N 0.000 description 1
- DNTFURVCRIGMPD-UHFFFAOYSA-N C1=CC=C2C(=C1)N3C(=C(N=C3S2)C(=O)O)F Chemical compound C1=CC=C2C(=C1)N3C(=C(N=C3S2)C(=O)O)F DNTFURVCRIGMPD-UHFFFAOYSA-N 0.000 description 1
- AUAOPHWOPQMLPT-UHFFFAOYSA-N C1COCC2=C1N1C=C(C(=O)OCC)N=C1S2 Chemical compound C1COCC2=C1N1C=C(C(=O)OCC)N=C1S2 AUAOPHWOPQMLPT-UHFFFAOYSA-N 0.000 description 1
- HYINPJDHLDRVAQ-UHFFFAOYSA-N C1COCC2=C1N1C=C(C=O)N=C1S2 Chemical compound C1COCC2=C1N1C=C(C=O)N=C1S2 HYINPJDHLDRVAQ-UHFFFAOYSA-N 0.000 description 1
- WBEQQKYSHVEJSP-UHFFFAOYSA-N C1OCCC2=C1OC1=CC=NN21 Chemical compound C1OCCC2=C1OC1=CC=NN21 WBEQQKYSHVEJSP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 101000740462 Escherichia coli Beta-lactamase TEM Proteins 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- YRJCEXLGTXWVQJ-UHFFFAOYSA-N FC1=C(CBr)C=CC=C1.FC1=C(CN2N=C(C=C2C(=O)O)C(=O)O)C=CC=C1 Chemical compound FC1=C(CBr)C=CC=C1.FC1=C(CN2N=C(C=C2C(=O)O)C(=O)O)C=CC=C1 YRJCEXLGTXWVQJ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical compound CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- JCDVLXZUQHRAIC-YFHOEESVSA-N N=1C=CN2C1SC1=C2C=CC(=C1)\C=C\1/C2SC=CN2C1=O Chemical compound N=1C=CN2C1SC1=C2C=CC(=C1)\C=C\1/C2SC=CN2C1=O JCDVLXZUQHRAIC-YFHOEESVSA-N 0.000 description 1
- FMKZFUMPALOTHD-UHFFFAOYSA-N O1C=2N(C=C1C=O)N=CC2 Chemical compound O1C=2N(C=C1C=O)N=CC2 FMKZFUMPALOTHD-UHFFFAOYSA-N 0.000 description 1
- KADVEDXGWJXWCG-UHFFFAOYSA-N OC(C1=CC2=NCOC2=CN1)=O Chemical compound OC(C1=CC2=NCOC2=CN1)=O KADVEDXGWJXWCG-UHFFFAOYSA-N 0.000 description 1
- HORKCJNPFWUARU-UHFFFAOYSA-N OC(C1N2N=CN=C2N=CC1)=O Chemical compound OC(C1N2N=CN=C2N=CC1)=O HORKCJNPFWUARU-UHFFFAOYSA-N 0.000 description 1
- VVXSVUWXTPRCSP-UHFFFAOYSA-N OC(C1OC2=CNC(C(O)=O)=CC2=N1)=O Chemical compound OC(C1OC2=CNC(C(O)=O)=CC2=N1)=O VVXSVUWXTPRCSP-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- PIVRJDREWXGRMO-UHFFFAOYSA-N S1C2=NC=CN2C2=C1CCC2 Chemical compound S1C2=NC=CN2C2=C1CCC2 PIVRJDREWXGRMO-UHFFFAOYSA-N 0.000 description 1
- JJRBNICLADQLAB-UHFFFAOYSA-N SC=1NC2=C(N1)C=CC=C2.S2C=1N(C=C2C=O)C2=C(N1)C=CC=C2 Chemical compound SC=1NC2=C(N1)C=CC=C2.S2C=1N(C=C2C=O)C2=C(N1)C=CC=C2 JJRBNICLADQLAB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- PHTMVIAGTMTVSK-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1=CC=CN2N=C(N)N=C21 PHTMVIAGTMTVSK-UHFFFAOYSA-N 0.000 description 1
- SRNKZYRMFBGSGE-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyrimidine Chemical compound N1=CC=CN2N=CN=C21 SRNKZYRMFBGSGE-UHFFFAOYSA-N 0.000 description 1
- NMQCJJLNAMAJAU-UHFFFAOYSA-N [1,3]thiazolo[3,2-a]benzimidazole-2-carboxylic acid Chemical compound C1=CC=C2N3C=C(C(=O)O)SC3=NC2=C1 NMQCJJLNAMAJAU-UHFFFAOYSA-N 0.000 description 1
- AQSYSRDNJKBQRY-UHFFFAOYSA-N [N+](=O)([O-])C1=CC=C(COC(=O)C=2N3C(C(C3SC2)(Br)C(C2=CC3=C(N=C4SCCN43)C=C2)OC(C)=O)=O)C=C1.CC(=CCCCC)C(=O)O Chemical compound [N+](=O)([O-])C1=CC=C(COC(=O)C=2N3C(C(C3SC2)(Br)C(C2=CC3=C(N=C4SCCN43)C=C2)OC(C)=O)=O)C=C1.CC(=CCCCC)C(=O)O AQSYSRDNJKBQRY-UHFFFAOYSA-N 0.000 description 1
- GOPYZMJAIPBUGX-UHFFFAOYSA-N [O-2].[O-2].[Mn+4] Chemical class [O-2].[O-2].[Mn+4] GOPYZMJAIPBUGX-UHFFFAOYSA-N 0.000 description 1
- 125000004062 acenaphthenyl group Chemical group C1(CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000003418 alkyl amino alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000002829 antibacterial sensitivity test Methods 0.000 description 1
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000005324 aryloxy alkyloxy group Chemical group 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 108010085672 beta-lactamase PSE-2 Proteins 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- RLYFCCSEWJKCQN-SMDADKPZSA-N chembl1206419 Chemical compound C1OCCC2=C1OC1=CC(\C=C3/C(=O)N4[C@@H]3SC=C4C(=O)O)=NN12 RLYFCCSEWJKCQN-SMDADKPZSA-N 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- OAIVIYSBZFEOIU-UHFFFAOYSA-N chloroform;propan-2-one Chemical compound CC(C)=O.ClC(Cl)Cl OAIVIYSBZFEOIU-UHFFFAOYSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- NPUACKRELIJTFM-UHFFFAOYSA-N cr gas Chemical group C1=NC2=CC=CC=C2OC2=CC=CC=C21 NPUACKRELIJTFM-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 description 1
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004582 dihydrobenzothienyl group Chemical group S1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000005435 dihydrobenzoxazolyl group Chemical group O1C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000005049 dihydrooxadiazolyl group Chemical group O1N(NC=C1)* 0.000 description 1
- 125000005050 dihydrooxazolyl group Chemical group O1C(NC=C1)* 0.000 description 1
- 125000005051 dihydropyrazinyl group Chemical group N1(CC=NC=C1)* 0.000 description 1
- 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 description 1
- 125000005054 dihydropyrrolyl group Chemical group [H]C1=C([H])C([H])([H])C([H])([H])N1* 0.000 description 1
- 125000005044 dihydroquinolinyl group Chemical group N1(CC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 description 1
- 125000005057 dihydrothienyl group Chemical group S1C(CC=C1)* 0.000 description 1
- 125000005058 dihydrotriazolyl group Chemical group N1(NNC=C1)* 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- XMTLHBWHJXNMJV-CLBCXVIASA-N ethyl 2-[(acetyloxy)((5r)-6-bromo-2-{[(4-nitrobenzyl)oxy]carbonyl}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-en-6-yl)methyl]-8,9-dihydropyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidine-7(6h)-carboxylate Chemical compound S([C@@H]1C(C(N11)=O)(Br)C(OC(C)=O)C=2N=C3N=CC4=C(N3N=2)CCN(C4)C(=O)OCC)C=C1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 XMTLHBWHJXNMJV-CLBCXVIASA-N 0.000 description 1
- DKTTUYJVGBVDHJ-UHFFFAOYSA-N ethyl 2-formyl-7,8-dihydro-5h-pyrazolo[1,2][1,3]oxazolo[2,3-a]pyridine-6-carboxylate Chemical compound C1N(C(=O)OCC)CCC2=C1OC1=CC(C=O)=NN21 DKTTUYJVGBVDHJ-UHFFFAOYSA-N 0.000 description 1
- WSOZZGXLSIXFDZ-UHFFFAOYSA-N ethyl 3-(dimethylaminomethylidene)-4-oxopiperidine-1-carboxylate Chemical compound CCOC(=O)N1CCC(=O)C(=CN(C)C)C1 WSOZZGXLSIXFDZ-UHFFFAOYSA-N 0.000 description 1
- DVJZXYGZKFZHQX-UHFFFAOYSA-N ethyl 3-bromo-4-oxopiperidine-1-carboxylate Chemical compound CCOC(=O)N1CCC(=O)C(Br)C1 DVJZXYGZKFZHQX-UHFFFAOYSA-N 0.000 description 1
- HRXRCEDKDQGLIW-UHFFFAOYSA-N ethyl 5,6,7,8-tetrahydroimidazo[1,2][1,2,4]triazolo[2,4-a]pyridine-2-carboxylate Chemical compound C1CCCC2=NC3=NC(C(=O)OCC)=CN3N21 HRXRCEDKDQGLIW-UHFFFAOYSA-N 0.000 description 1
- GXRORGSRKVGBFW-UHFFFAOYSA-N ethyl 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]benzoxazole-2-carboxylate Chemical compound C1CCCC2=C1OC1=CC(C(=O)OCC)=NN12 GXRORGSRKVGBFW-UHFFFAOYSA-N 0.000 description 1
- VMTUPCLFULPHMX-UHFFFAOYSA-N ethyl 6-chloroimidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound ClC1=CC=C2N3C=C(C(=O)OCC)N=C3SC2=C1 VMTUPCLFULPHMX-UHFFFAOYSA-N 0.000 description 1
- UZDXFYLOOANIJW-UHFFFAOYSA-N ethyl 6-fluoroimidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound FC1=CC=C2N3C=C(C(=O)OCC)N=C3SC2=C1 UZDXFYLOOANIJW-UHFFFAOYSA-N 0.000 description 1
- UHKUIINEEJIQHE-UHFFFAOYSA-N ethyl 6-methoxyimidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound COC1=CC=C2N3C=C(C(=O)OCC)N=C3SC2=C1 UHKUIINEEJIQHE-UHFFFAOYSA-N 0.000 description 1
- DHUOZZWPEJRSGY-UHFFFAOYSA-N ethyl 6-methylimidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound CC1=CC=C2N3C=C(C(=O)OCC)N=C3SC2=C1 DHUOZZWPEJRSGY-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- REOXQBVMMDCPSB-UHFFFAOYSA-N ethyl imidazo[2,1-b][1,3]benzothiazole-2-carboxylate Chemical compound C1=CC=C2N3C=C(C(=O)OCC)N=C3SC2=C1 REOXQBVMMDCPSB-UHFFFAOYSA-N 0.000 description 1
- YSPVHAUJXLGZHP-UHFFFAOYSA-N ethyl piperidine-1-carboxylate Chemical compound CCOC(=O)N1CCCCC1 YSPVHAUJXLGZHP-UHFFFAOYSA-N 0.000 description 1
- UAYKGOMDUQLCJS-UHFFFAOYSA-N ethylsulfanyl acetate Chemical compound CCSOC(C)=O UAYKGOMDUQLCJS-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 244000000058 gram-negative pathogen Species 0.000 description 1
- 244000000059 gram-positive pathogen Species 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000005114 heteroarylalkoxy group Chemical group 0.000 description 1
- 125000005367 heteroarylalkylthio group Chemical group 0.000 description 1
- 125000005368 heteroarylthio group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- HJMONQQZFQKQPS-UHFFFAOYSA-N imidazo[1,2-a]quinoline Chemical compound C1=CC=C2N3C=CN=C3C=CC2=C1 HJMONQQZFQKQPS-UHFFFAOYSA-N 0.000 description 1
- VTNBGTYLJIUATL-UHFFFAOYSA-N imidazo[1,2-a]quinoxaline Chemical compound C1=CC=C2N3C=CN=C3C=NC2=C1 VTNBGTYLJIUATL-UHFFFAOYSA-N 0.000 description 1
- DUMVHAOYEAJYGD-UHFFFAOYSA-N imidazo[1,2-a]quinoxaline-2-carbaldehyde Chemical compound C1=CC=C2N3C=C(C=O)N=C3C=NC2=C1.C1=CC=C2N3C=C(C=O)N=C3C=NC2=C1 DUMVHAOYEAJYGD-UHFFFAOYSA-N 0.000 description 1
- AYWXAXVILRRBCO-UHFFFAOYSA-N imidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde Chemical compound C1=CC=C2N3C=C(C=O)N=C3SC2=C1 AYWXAXVILRRBCO-UHFFFAOYSA-N 0.000 description 1
- UFBBWLWUIISIPW-UHFFFAOYSA-N imidazo[2,1-b][1,3]thiazole Chemical compound C1=CSC2=NC=CN21 UFBBWLWUIISIPW-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960002260 meropenem Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- DVLGIQNHKLWSRU-UHFFFAOYSA-N methyl 1h-imidazole-5-carboxylate Chemical compound COC(=O)C1=CN=CN1 DVLGIQNHKLWSRU-UHFFFAOYSA-N 0.000 description 1
- AJBAARXWXGXERD-UHFFFAOYSA-N methyl 6-oxo-5h-benzo[b][1,4]benzoxazepine-3-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2OC2=CC=CC=C21 AJBAARXWXGXERD-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 108010071437 oxacillinase Proteins 0.000 description 1
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- SEHTVUUNNBWQMN-UHFFFAOYSA-N pyrazolo[5,1-b][1,3]oxazole-2-carboxylic acid Chemical compound N1=CC=C2OC(C(=O)O)=CN21 SEHTVUUNNBWQMN-UHFFFAOYSA-N 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- GDDZRTPUGYRYNK-UYTGOYFPSA-M sodium;(6z)-7-oxo-6-(5,6,7,8-tetrahydroimidazo[1,2][1,2,4]triazolo[2,4-a]pyridin-2-ylmethylidene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Na+].C1CCCC2=NC3=NC(/C=C4/C(=O)N5C4SC=C5C(=O)[O-])=CN3N21 GDDZRTPUGYRYNK-UYTGOYFPSA-M 0.000 description 1
- IYNZNZWNBXJNNC-UHFFFAOYSA-M sodium;1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1=CCC2CCN12 IYNZNZWNBXJNNC-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 229960004932 sulbenicillin Drugs 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229940041007 third-generation cephalosporins Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68622105P | 2005-06-01 | 2005-06-01 | |
| PCT/US2006/020410 WO2007030166A2 (en) | 2005-06-01 | 2006-05-25 | TRICYCLIC 6-ALKYLIDENE-PENEMS AS CLASS-D β-LACTAMASES INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008542376A true JP2008542376A (ja) | 2008-11-27 |
| JP2008542376A5 JP2008542376A5 (enExample) | 2009-06-04 |
Family
ID=37836305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514712A Withdrawn JP2008542376A (ja) | 2005-06-01 | 2006-05-25 | クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060276446A1 (enExample) |
| EP (1) | EP1885358A2 (enExample) |
| JP (1) | JP2008542376A (enExample) |
| CN (1) | CN101189010A (enExample) |
| AR (1) | AR054467A1 (enExample) |
| AU (1) | AU2006287938A1 (enExample) |
| BR (1) | BRPI0611491A2 (enExample) |
| CA (1) | CA2610478A1 (enExample) |
| GT (1) | GT200600235A (enExample) |
| MX (1) | MX2007015173A (enExample) |
| PE (1) | PE20070010A1 (enExample) |
| SV (1) | SV2007002555A (enExample) |
| TW (1) | TW200716104A (enExample) |
| WO (1) | WO2007030166A2 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009517029A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | 食物繊維を含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
| JP2009517032A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | プロバイオティクス/プレバイオティクスを含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
| WO2010098332A1 (ja) * | 2009-02-26 | 2010-09-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 多環式化合物の製造法およびその中間体 |
| US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
| US20110288063A1 (en) * | 2010-05-19 | 2011-11-24 | Naeja Pharmaceutical Inc. | Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors |
| CN104341345B (zh) * | 2014-10-24 | 2016-03-23 | 海门海康生物医药科技有限公司 | 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法 |
| WO2020179859A1 (ja) | 2019-03-06 | 2020-09-10 | 第一三共株式会社 | ピロロピラゾール誘導体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2206502T3 (es) * | 1994-04-25 | 2004-05-16 | Smithkline Beecham Plc | Formulaciones farmaceuticas que contienen un penem inhibidor de beta-lactamasa en combinacion con un antibiotico de beta-lactama y su uso en el tratamiento de infecciones bacterianas. |
| US20040132706A1 (en) * | 2001-10-05 | 2004-07-08 | Daniela Salvemini | Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| US20040132708A1 (en) * | 2002-05-01 | 2004-07-08 | Wyeth | Process for preparing 6-alkylidene penem derivatives |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039476A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | Proceso para preparar derivados de 6-alquiliden penem |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
-
2006
- 2006-05-22 TW TW095118171A patent/TW200716104A/zh unknown
- 2006-05-25 MX MX2007015173A patent/MX2007015173A/es unknown
- 2006-05-25 BR BRPI0611491-1A patent/BRPI0611491A2/pt not_active IP Right Cessation
- 2006-05-25 JP JP2008514712A patent/JP2008542376A/ja not_active Withdrawn
- 2006-05-25 AU AU2006287938A patent/AU2006287938A1/en not_active Abandoned
- 2006-05-25 CN CNA2006800193154A patent/CN101189010A/zh active Pending
- 2006-05-25 WO PCT/US2006/020410 patent/WO2007030166A2/en not_active Ceased
- 2006-05-25 EP EP06824758A patent/EP1885358A2/en not_active Withdrawn
- 2006-05-25 CA CA002610478A patent/CA2610478A1/en not_active Abandoned
- 2006-05-31 PE PE2006000563A patent/PE20070010A1/es not_active Application Discontinuation
- 2006-05-31 SV SV2006002555A patent/SV2007002555A/es unknown
- 2006-05-31 US US11/444,346 patent/US20060276446A1/en not_active Abandoned
- 2006-06-01 GT GT200600235A patent/GT200600235A/es unknown
- 2006-06-01 AR ARP060102292A patent/AR054467A1/es unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009517029A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | 食物繊維を含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
| JP2009517032A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | プロバイオティクス/プレバイオティクスを含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
| US8512789B2 (en) | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US8524304B2 (en) | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
| US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
| WO2010098332A1 (ja) * | 2009-02-26 | 2010-09-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 多環式化合物の製造法およびその中間体 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007030166A2 (en) | 2007-03-15 |
| WO2007030166A3 (en) | 2007-05-24 |
| EP1885358A2 (en) | 2008-02-13 |
| GT200600235A (es) | 2007-03-29 |
| US20060276446A1 (en) | 2006-12-07 |
| SV2007002555A (es) | 2007-02-02 |
| MX2007015173A (es) | 2008-02-15 |
| AU2006287938A1 (en) | 2007-03-15 |
| AR054467A1 (es) | 2007-06-27 |
| CN101189010A (zh) | 2008-05-28 |
| CA2610478A1 (en) | 2007-03-15 |
| TW200716104A (en) | 2007-05-01 |
| BRPI0611491A2 (pt) | 2010-12-21 |
| PE20070010A1 (es) | 2007-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7691842B2 (en) | Tricyclic 6-alkylidene-penems as β-lactamase inhibitors | |
| US7812014B2 (en) | Bicyclic 6-alkylidene-penems as β-lactamase inhibitors | |
| JP2008542376A (ja) | クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 | |
| US20040132708A1 (en) | Process for preparing 6-alkylidene penem derivatives | |
| US20060276445A1 (en) | Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors | |
| US20070232582A1 (en) | 4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors | |
| US7229983B2 (en) | 4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors | |
| HK1124064A (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090414 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090414 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100401 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100414 |